LAROSA JOSEPH J 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed May 22, 2024
Insider Transaction Report
Form 4
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
- Sale
Common Stock
2024-05-21$994.90/sh−1,865$1,855,489→ 34,678 total
Holdings
- 371(indirect: By 401(k))
Common Stock
- 3,367(indirect: 2022 GRAT)
Common Stock
Footnotes (1)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2024.